A comprehensive analysis of the impact of smoking on adverse clinical outcomes of steatotic liver diseases
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is an increasingly prevalent liver disorder. Objectives: This study investigated the effect of smoking status on various clinical outcomes in MASLD and metabol...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-04-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/17562848251331315 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|